Anaerostipes hadrus for use in promoting health
AssigneesSecond Genome, Inc., University College Cork, National University of Ireland
InventorsShoko Kawana, Todd Z. DeSantis, Marcus J. Claesson, Feargal J. Ryan
Life of this patent
Estimating the term…
Abstract
The disclosure relates to live biotherapeutic products, probiotics, pharmaceutical compositions comprising said probiotics, and methods of using them to treat a gastrointestinal disease or disorder. In some aspects, the disclosure provides such compositions comprising strains of the bacterium Anaerostipes hadrus and their uses in treating intestinal diseases or disorders.
Claims13
A method for treating a subject in need thereof, the method comprising administering to the subject a composition comprising a therapeutically effective amount of a bacterium, wherein the bacterium has a 16S RNA gene that is at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identical to SEQ ID NO:8.
A method for maintaining or improving overall fitness or health of a patient, said method comprising:
- administering to the patient a therapeutic composition comprising:
- i. an effective amount of a composition comprising a bacterium, wherein the bacterium has a 16S RNA gene that is at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identical to SEQ ID NO:8;
- and
- ii. a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.